Raynauds Disease Global Clinical Trials Review, H2, 2013
London (PRWEB) November 27, 2013 -- Raynauds Disease Global Clinical Trials Review, H2, 2013
Summary
GlobalData's clinical trial report, “Raynauds Disease Global Clinical Trials Review, H2, 2013" provides data on the Raynauds Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Raynauds Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Raynauds Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
-Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
-Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
-Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
-Understand the dynamics of a particular indication in a condensed manner
-Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
-Obtain discontinued trial listing for trials across the globe
-Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Raynauds Disease 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Raynauds Disease 23
Subjects Recruited Over a Period of Time 24
Prominent Sponsors 25
Top Companies Participating in Raynauds Disease Therapeutics Clinical Trials 27
Prominent Drug Comparison 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
MediQuest Therapeutics, Inc. 30
Clinical Trial Overview of MediQuest Therapeutics, Inc. 30
Orion Oyj 31
Clinical Trial Overview of Orion Oyj 31
Pfizer Inc. 32
Clinical Trial Overview of Pfizer Inc. 32
Pharmarama International Limited 33
Clinical Trial Overview of Pharmarama International Limited 33
Procris Pharmaceuticals 34
Clinical Trial Overview of Procris Pharmaceuticals 34
VSM Geneesmiddelen bv 35
Clinical Trial Overview of VSM Geneesmiddelen bv 35
Otsuka Pharmaceutical Co., Ltd. 36
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 36
Surface Logix, Inc. 37
Clinical Trial Overview of Surface Logix, Inc. 37
Otsuka America Pharmaceutical, Inc. 38
Clinical Trial Overview of Otsuka America Pharmaceutical, Inc. 38
Apricus Biosciences, Inc. 39
Clinical Trial Overview of Apricus Biosciences, Inc. 39
Bayer AG 40
Clinical Trial Overview of Bayer AG 40
Clinical Trial Overview of Top Institutes / Government 41
Sanjay Gandhi Postgraduate Institute of Medical Sciences 41
Clinical Trial Overview of Sanjay Gandhi Postgraduate Institute of Medical Sciences 41
Royal National Hospital for Rheumatic Diseases 42
Clinical Trial Overview of Royal National Hospital for Rheumatic Diseases 42
Gottfried Wilhelm Leibniz University Hannover 43
Clinical Trial Overview of Gottfried Wilhelm Leibniz University Hannover 43
Alexandria University 44
Clinical Trial Overview of Alexandria University 44
Southern Illinois University 45
Clinical Trial Overview of Southern Illinois University 45
Azienda Ospedaliera Universitaria San Martino 46
Clinical Trial Overview of Azienda Ospedaliera Universitaria San Martino 46
Mashhad University of Medical Sciences 47
Clinical Trial Overview of Mashhad University of Medical Sciences 47
University of Freiburg 48
Clinical Trial Overview of University of Freiburg 48
Charite - Universitatsmedizin Berlin 49
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 49
Seoul National University Hospital 50
Clinical Trial Overview of Seoul National University Hospital 50
The Medical University of Graz 51
Clinical Trial Overview of The Medical University of Graz 51
University of Cologne 52
Clinical Trial Overview of University of Cologne 52
Northwestern University 53
Clinical Trial Overview of Northwestern University 53
University of Michigan 54
Clinical Trial Overview of University of Michigan 54
Emory University 55
Clinical Trial Overview of Emory University 55
Federal University of Sao Paulo 56
Clinical Trial Overview of Federal University of Sao Paulo 56
National Center for Research Resources 57
Clinical Trial Overview of National Center for Research Resources 57
Lawson Health Research Institute 58
Clinical Trial Overview of Lawson Health Research Institute 58
University of Medicine and Dentistry New Jersey 59
Clinical Trial Overview of University of Medicine and Dentistry New Jersey 59
Johns Hopkins University 60
Clinical Trial Overview of Johns Hopkins University 60
Five Key Clinical Profiles 61
Appendix 99
Abbreviations 99
Definitions 99
Research Methodology 100
Secondary Research 100
About GlobalData 101
Contact Us 101
Disclaimer 101
Source 102
List of Tables
Raynauds Disease Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Raynauds Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Raynauds Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Raynauds Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013* 10
Raynauds Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Raynauds Disease Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Raynauds Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 13
Raynauds Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 14
Raynauds Disease Therapeutics Clinical Trials, BRIC Countries, 2013* 15
Raynauds Disease Therapeutics Clinical Trials, G7 Countries, 2013* 16
Raynauds Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Raynauds Disease Therapeutics Clinical Trials, E7 Countries, 2013* 18
Raynauds Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Raynauds Disease Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
Raynauds Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21
Raynauds Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Raynauds Disease Therapeutics Market, Global, Terminated Clinical Trials, 2013* 23
Raynauds Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 24
Raynauds Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 26
Raynauds Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 28
Raynauds Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 29
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by MediQuest Therapeutics, Inc., 2013* 30
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Orion Oyj, 2013* 31
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 32
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmarama International Limited, 2013* 33
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Procris Pharmaceuticals, 2013* 34
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by VSM Geneesmiddelen bv, 2013* 35
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2013* 36
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Surface Logix, Inc., 2013* 37
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka America Pharmaceutical, Inc., 2013* 38
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Apricus Biosciences, Inc., 2013* 39
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013* 40
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanjay Gandhi Postgraduate Institute of Medical Sciences, 2013* 41
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal National Hospital for Rheumatic Diseases, 2013* 42
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Gottfried Wilhelm Leibniz University Hannover, 2013* 43
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexandria University, 2013* 44
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Southern Illinois University, 2013* 45
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria San Martino, 2013* 46
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2013* 47
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Freiburg, 2013* 48
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2013* 49
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2013* 50
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2013* 51
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cologne, 2013* 52
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2013* 53
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2013* 54
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2013* 55
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2013* 56
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2013* 57
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2013* 58
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2013* 59
Raynauds Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013* 60
List of Figures
Raynauds Disease Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Raynauds Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Raynauds Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Raynauds Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2013* 10
Raynauds Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Raynauds Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
Raynauds Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 13
Raynauds Disease Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 14
Raynauds Disease Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15
Raynauds Disease Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
Raynauds Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Raynauds Disease Therapeutics Clinical Trials, E7 Countries (%), 2013* 18
Raynauds Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Raynauds Disease Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
Raynauds Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
Raynauds Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Raynauds Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 24
Raynauds Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 25
Raynauds Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 27
Raynauds Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 29
GlobalData Methodology 100
Read the full report:
Raynauds Disease Global Clinical Trials Review, H2, 2013
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com
Sarah Smith, Research Advisor at Reportbuyer.com, +44 208 816 85 48, [email protected]
Share this article